Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
About this item
Full title
Author / Creator
Publisher
New York, NY: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Toxic acute tubular necrosis following treatment with zoledronate (Zometa).
Renal failure and toxic acute tubular necrosis (ATN) may be seen following exposure to a variety of therapeutic agents. Zoledronate (Zometa) is a new, highly potent bisphosphonate used in the treatment of hypercalcemia of malignancy. We report the first clinical-patholog...
Alternative Titles
Full title
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_210110682
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_210110682
Other Identifiers
ISSN
0085-2538
E-ISSN
1523-1755
DOI
10.1046/j.1523-1755.2003.00071.x
